Excellent entry point for SYN after move from Golden Cross
Expect this stock to move upwards.
SYN, is displaying a descending triangle off of a big move and has support at 2.30.
As highlighted on Bulkwoski's site (thepatternsite.com/dt.html): "If price rises into the pattern it breaks out upward 73% of the time."
This company 4 drugs ... one which has shown to improve MS patients, and another which address C Diff. C Diff has been declared by the CDC as in need of national focus. Shortly afterwards, C Diff caused Toronto's largest hospital to shut down a part of its cardiovascular unit. news.nationalpost.com/2015/02/11/torontos-largest-hospital-shuts-down-part-of-cardiovascular-unit-after-c-difficile-outbreak/. SYN is the only company to have a drug in the pipe that address C Diff.
This seeking alpha article does an excellent job summing up the potential in more depth for the pipeline.
seekingalpha.com/article/2902236-synthetic-biologics-a-speculative-small-cap-packed-with-power
This link from the SYN site, nicely sums up the pipeline:
syntheticbiologics.com/index.php?s=99
Overall, this company is extremely undervalued and is primed for huge moves over the next several weeks as news of it's MS drug comes out.
SYN, is displaying a descending triangle off of a big move and has support at 2.30.
As highlighted on Bulkwoski's site (thepatternsite.com/dt.html): "If price rises into the pattern it breaks out upward 73% of the time."
This company 4 drugs ... one which has shown to improve MS patients, and another which address C Diff. C Diff has been declared by the CDC as in need of national focus. Shortly afterwards, C Diff caused Toronto's largest hospital to shut down a part of its cardiovascular unit. news.nationalpost.com/2015/02/11/torontos-largest-hospital-shuts-down-part-of-cardiovascular-unit-after-c-difficile-outbreak/. SYN is the only company to have a drug in the pipe that address C Diff.
This seeking alpha article does an excellent job summing up the potential in more depth for the pipeline.
seekingalpha.com/article/2902236-synthetic-biologics-a-speculative-small-cap-packed-with-power
This link from the SYN site, nicely sums up the pipeline:
syntheticbiologics.com/index.php?s=99
Overall, this company is extremely undervalued and is primed for huge moves over the next several weeks as news of it's MS drug comes out.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.